Newsroom | 101864 results

PALO ALTO, Calif.--(BUSINESS WIRE)--Spot Biosystems launches with $40M financing and world-first non-viral delivery of full-length dystrophin in animal models and human patients with DMD...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies announces pricing of a public offering....

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinical data on Arrivo Bio’s RABI-767 program will be presented at the 58th European Pancreatic Club (EPC)/International Association of Pancreatology (IAP) Annual Meeting, taking place June 24–27, 2026 in Istanbul, Turkey. The presentation will highlight RABI-767, a small molecule pancreatic lipase inhibitor in development for patients with predicted severe acute pancreatitis (SAP). RABI-767 is designed to inhibit pancreatic lipase activity and interrupt the...

AUSTIN, Texas--(BUSINESS WIRE)--Paradromics Inc., a neurotechnology company that has developed the highest data-rate brain-computer interface (BCI) platform, announced today the completion of the first surgical implantation in the FDA-approved Connect-One Early Feasibility Study (EFS) at University of Michigan Health. The procedure was performed by Matthew Willsey, M.D., Ph.D., a neurosurgeon and biomedical engineer, with Aditya S. Pandey, M.D., and a multidisciplinary team of providers. The Co...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc., a global leader in women’s health, today released its 2025 Sustainability Report. The new report coincides with Hologic’s 40th anniversary and underscores how the company’s longstanding purpose — to enable healthier lives for women everywhere, every day — continues to drive progress for patients, communities and the planet. “We have always firmly believed that our success as a company is fundamentally tied to our ability and commitment to help...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion medicine experts and professionals from around the world are expected to attend the ISBT Congress. “We look forward to highlighting how blood centers around the world are l...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational Device Exemption (IDE) application to initiate the RELIEF study. RELIEF is a feasibility study evaluating irreversible electroporation (IRE), the non-...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Bortezomib for Injection in the United States. The product contains the same active ingredient as VELCADE®, as approved by the U.S. Food and Drug Administration, and is indicated for the treatment of adults with multiple myeloma and mantle cell lymphoma. Bortezomib for Injection is available as a carton of one 3.5 mg single-dose via...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Verici Dx, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that collaborators will present new data on the predictive performance of its Tutivia™ test at the American Transplant Congress (ATC) Annual Meeting, taking place June 20–24, 2026 in Boston. The abstracts are available via the planner on the ATC website. The two poster presentations, delivered by leading transplant clinicians, describe the ability of Tutiv...

SINGAPORE & SAN FRANCISCO--(BUSINESS WIRE)--Gero secures $17M in new financing, bringing total funding to $34M to advance AI-driven drug discovery for aging and chronic diseases....